Februar 17, 2019
  INTRODUCTION: Major depressive disorder (MDD) is a highly prevalent illness, estimated being the second leading cause of disability by the year 2020. Considering the obvious insufficiency of the current, primarily pharmaceutical oriented treatment paradigm, manifesting itself in high rates of recurrence, side effects and treatment resistance among those affected by this disease, new treatment...
Lesen Sie mehr